ReviewInternational journal of molecular sciences2018

Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late.

Michiel Remmerie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.